Jonsson F - Search Results

1

Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.

Ou Y, Doshi S, Nguyen A, Jonsson F, Aggarwal S, Rajangam K, Dimopoulos MA, Stewart AK, Badros A, Papadopoulos KP, Siegel D, Jagannath S, Vij R, Niesvizky R, Graham R, Visich J. Ou Y, et al. Among authors: jonsson f. J Clin Pharmacol. 2017 May;57(5):663-677. doi: 10.1002/jcph.850. Epub 2016 Dec 7. J Clin Pharmacol. 2017. PMID: 27925676 Clinical Trial.

2

A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use.

Jonsson F, Ou Y, Claret L, Siegel D, Jagannath S, Vij R, Badros A, Aggarwal S, Bruno R. Jonsson F, et al. CPT Pharmacometrics Syst Pharmacol. 2015 Dec;4(12):711-9. doi: 10.1002/psp4.12044. Epub 2015 Nov 20. CPT Pharmacometrics Syst Pharmacol. 2015. PMID: 26904385 Free PMC article.

3

Exposure-Response and Tumor Growth Inhibition Analyses of the Monovalent Anti-c-MET Antibody Onartuzumab (MetMAb) in the Second- and Third-Line Non-Small Cell Lung Cancer.

Han K, Chanu P, Jonsson F, Winter H, Bruno R, Jin J, Stroh M. Han K, et al. Among authors: jonsson f. AAPS J. 2017 Mar;19(2):527-533. doi: 10.1208/s12248-016-0029-5. Epub 2016 Dec 27. AAPS J. 2017. PMID: 28028730 Clinical Trial.

4

Adjustment factors for toluene, styrene and methyl chloride by population modeling of toxicokinetic variability.

Mörk AK, Jonsson F, Johanson G. Mörk AK, et al. Among authors: jonsson f. Regul Toxicol Pharmacol. 2014 Jun;69(1):78-90. doi: 10.1016/j.yrtph.2014.02.015. Epub 2014 Mar 6. Regul Toxicol Pharmacol. 2014. PMID: 24613484

5

Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.

Jonsson F, Johanson G. Jonsson F, et al. Toxicol Appl Pharmacol. 2002 Feb 15;179(1):35-49. doi: 10.1006/taap.2001.9331. Toxicol Appl Pharmacol. 2002. PMID: 11884235 Clinical Trial.

6

The Bayesian population approach to physiological toxicokinetic-toxicodynamic models--an example using the MCSim software.

Jonsson F, Johanson G. Jonsson F, et al. Toxicol Lett. 2003 Feb 18;138(1-2):143-50. doi: 10.1016/s0378-4274(02)00369-7. Toxicol Lett. 2003. PMID: 12559698 Review.

7

Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.

Mörk AK, Jonsson F, Johanson G. Mörk AK, et al. Among authors: jonsson f. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):423-32. doi: 10.1016/j.taap.2009.07.033. Epub 2009 Aug 4. Toxicol Appl Pharmacol. 2009. PMID: 19660484

8

Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.

Jonsson F, Johanson G. Jonsson F, et al. Toxicology. 2001 Jan 26;157(3):177-93. doi: 10.1016/s0300-483x(00)00356-5. Toxicology. 2001. PMID: 11164983

9

Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects.

Jonsson F, Bois FY, Johanson G. Jonsson F, et al. Arch Toxicol. 2001 Jun;75(4):189-99. doi: 10.1007/s002040100221. Arch Toxicol. 2001. PMID: 11482516

10

A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane.

Jonsson F, Johanson G. Jonsson F, et al. Toxicol Appl Pharmacol. 2001 Jul 15;174(2):99-112. doi: 10.1006/taap.2001.9206. Toxicol Appl Pharmacol. 2001. PMID: 11446825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters